X0508 4 2025-12-31 0 0001326110 ImmunityBio, Inc. IBRX 0001848899 Sachs David C. C/O IMMUNITYBIO, INC. 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer 0 Common Stock 2025-12-31 4 M 0 30397 0 A 256017 D Common Stock 2025-12-31 4 F 0 15435 1.98 D 240582 D Restricted Stock Units 2025-12-31 4 M 0 30397 0 D Common Stock 30397 45602 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock. On December 31, 2025, the Reporting Person's RSUs vested. The closing price of Immunity Bio, Inc.'s common stock on December 30, 2025 was the settlement price used to calculate the shares withheld. 17,242 of the RSUs vested on December 9, 2021. Five percent (5%) of the remaining 151,989 RSUs (rounded down to the nearest whole share) vested on September 9, 2021; five percent (5%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2022; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2023; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2024; twenty percent (20%) of the RSUs (rounded down to the nearest whole share) vested on December 31, 2025; and the remaining RSUs will vest on December 31, 2026. Exhibit 24 - Power of Attorney /s/ Philip LoScalzo, as Attorney-in-Fact 2026-01-05